The Clorox Company (NYSE:CLX) remains in the limelight with multiple updates. Despite receiving a “Reduce” rating from brokerages, CLX's stock outperformed competitors on numerous trading days while being recognised as Barron's Most Sustainable U.S. Company for the second consecutive year. Several asset management firms, including Parsifal Capital Management and Point72 Asset Management, have significantly invested in the company. However, a few investment firms like Northern Trust Corp and Bollard Group LLC reduced their Clorox holdings. Also, it remains heavily dominated by institutional owners holding 80% of its shares. The company reported mixed Q3 and Q2 2024 results while updating the fiscal outlook. Further, its divestment in operations across Argentina, Uruguay, and Paraguay is significant. Despite facing challenges, CLX seems to benefit from strategic actions resulting in adjusted EPS rises and robust sales growth. However, critics claim the company’s stock has been overpriced, leading to occasional underperformance against competitors. The latest Q3 earnings beat estimates but revenues were down YoY. The board named Linda Rendle Chair, suggesting leadership renewal. With its IGNITE Strategy and ESG Goals, the future growth potential of CLX appears promising.
Clorox Company CLX News Analytics from Thu, 27 Jul 2023 07:00:00 GMT to Sun, 16 Jun 2024 09:27:50 GMT -
Rating 4
- Innovation 1
- Information 6
- Rumor -3
